NuCana
Edinburgh
About NuCana
NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our phosphoramidate chemistry technology to transform some of the most widely prescribed chemotherapy agents into more effective and safer medicines.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $67.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2014)
- Website: nucana.com
- Phone: +44 (0)131 357 1111
Industries & Categories
Clinical Trials
Social Profiles
Canonical: https://fsome.com/organization/nucana-189015 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.